EC Clinical and Medical Case Reports

Research Article Volume 6 Issue 4 - 2023

The Effectiveness of Intravenous Infusion Ozone Therapy in Patients with Fatty Hepatosis

Katyukhin VN* and Katyukhin LN

REAVIZ University, MC Euromedica, Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, (IEPhB RAS), Saint Petersburg, Russian Federation

*Corresponding Author: Katyukhin VN, REAVIZ University, MC Euromedica, Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, (IEPhB RAS), Saint Petersburg, Russian Federation.
Received: February 14, 2023; Published: March 20, 2023



Fatty hepatosis or non-alcoholic fatty liver disease is a condition in which more than 5% of hepatocytes accumulate fat, which occurs in the absence of excessive alcohol consumption. There are several types of the disease: 1) simple steatosis is a benign condition in which there is no inflammation, there is no progression of the pathological process in the liver, but cardiovascular diseases and their complications can progress; 2) non-alcoholic steatohepatitis, which, in addition to steatosis, is characterized by lobular inflammation, balloon degeneration and fibrosis of hepatocytes with the risk of progression to liver cirrhosis and the development of hepatocellular cancer [1]. The antioxidant function of the liver suffers significantly in such diseases due to functional and organic lesions of its parenchyma with the accumulation of lipid peroxidation products. Therapeutic correction of pathological products of altered metabolism is possible with the use of medical ozone. The entry of singlet oxygen molecules into the systemic circulation has an antioxidant, anti-inflammatory and detoxifying effect.

Keywords: Intravenous Infusion Ozone Therapy; Fatty Hepatosis; Hepatocellular Cancer

Katyukhin VN and Katyukhin LN. "The Effectiveness of Intravenous Infusion Ozone Therapy in Patients with Fatty Hepatosis". EC Clinical and Medical Case Reports   6.4 (2023): 113-115.